Veterinary clinical pathologists in the biopharmaceutical industry.
There is an international shortage of veterinary clinical pathologists in the workplace. Current trainees in veterinary clinical pathology may choose to pursue careers in academe, diagnostic laboratories, government health services, biopharmaceutical companies, or private practice. Academic training programs attempt to provide trainees with an exposure to several career choices. However, due to the proprietary nature of much of the work in the biopharmaceutical industry, trainees may not be fully informed regarding the nature of work for veterinary clinical pathologists and the myriad opportunities that await employment in the biopharmaceutical industry. The goals of this report are to provide trainees in veterinary clinical pathology and other laboratory personnel with an overview of the work-life of veterinary clinical pathologists employed in the biopharmaceutical industry, and to raise the profile of this career choice for those seeking to enter the workforce. Biographical sketches, job descriptions, and motivation for 3 successful veterinary clinical pathologists employed in the biopharmaceutical industry are provided. Current and past statistics for veterinary clinical pathologists employed in the biopharmaceutical industry are reviewed. An overview of the drug development process and involvement of veterinary clinical pathologists in the areas of discovery, lead optimization, and candidate evaluation are discussed. Additional duties for veterinary clinical pathologists employed in the biopharmaceutical industry include development of biomarkers and new technologies, service as scientific resources, diagnostic support services, and laboratory management responsibilities. There are numerous opportunities available for trainees in veterinary clinical pathology to pursue employment in the biopharmaceutical industry and enjoy challenging and rewarding careers.
Schultze
A Eric
AE
Department of Pathology, Lilly Research Laboratories, A Division of Eli Lilly and Company, Greenfield, IN, USA. aes@lilly.com
Bounous
Denise I
DI
Bolliger
Anne Provencher
AP
D015415:Biomarkers; D002986:Clinical Trials as Topic; D015195:Drug Design; D004345:Drug Industry / Q000639:trends; D015507:Drugs, Investigational; D010338:Pathology, Clinical / Q000639:trends; D013997:Time Factors; D018634:Veterinarians / Q000639:trends*; D000078329:Workforce
D015415:Biomarkers; D015507:Drugs, Investigational